Gts Securities »

Aurinia Pharmaceuticals shares owned by Gts Securities

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Gts Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 242k 8.99
2023-09-30 $1.7M 217k 7.77

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Tesla Motors Put Option (TSLA)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Costco Wholesale Corporation Put Option (COST)

View all positions for Gts Securities

Top funds holding Aurinia Pharmaceuticals

NEA Management Company
Goldman Sachs Group
Citadel Advisors
Vanguard Group
Citigroup
Balyasny Asset Management
Caption Management
Jane Street
Tang Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Stifel Financial
GSA Capital Partners
Nordea Investment Management Ab
Barclays

View all funds holding Aurinia Pharmaceuticals